Andrew Alt

2.6k total citations
46 papers, 1.9k citations indexed

About

Andrew Alt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics. According to data from OpenAlex, Andrew Alt has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 32 papers in Cellular and Molecular Neuroscience and 4 papers in Computational Theory and Mathematics. Recurrent topics in Andrew Alt's work include Receptor Mechanisms and Signaling (26 papers), Neuropeptides and Animal Physiology (22 papers) and Neuroscience and Neuropharmacology Research (13 papers). Andrew Alt is often cited by papers focused on Receptor Mechanisms and Signaling (26 papers), Neuropeptides and Animal Physiology (22 papers) and Neuroscience and Neuropharmacology Research (13 papers). Andrew Alt collaborates with scholars based in United States, Australia and United Kingdom. Andrew Alt's co-authors include David Bleakman, Eric S. Nisenbaum, John R. Traynor, Neil T. Burford, Jeffrey M. Witkin, J M Witkin, Mary J. Clark, Martyn Banks, J H Woods and Jonathan C. O’Connell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Monthly Notices of the Royal Astronomical Society.

In The Last Decade

Andrew Alt

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Alt United States 25 1.3k 1.1k 311 264 176 46 1.9k
Michael P. Johnson United States 25 1.8k 1.4× 1.1k 1.0× 260 0.8× 364 1.4× 128 0.7× 52 2.6k
David O. Calligaro United States 28 1.2k 0.9× 1.2k 1.1× 400 1.3× 287 1.1× 98 0.6× 75 2.4k
Т. А. Гудашева Russia 22 946 0.7× 771 0.7× 686 2.2× 155 0.6× 129 0.7× 299 1.8k
Theresa Kopajtic United States 29 1.8k 1.4× 1.5k 1.4× 235 0.8× 292 1.1× 73 0.4× 72 2.8k
С. Б. Середенин Russia 25 1.1k 0.9× 1.0k 0.9× 657 2.1× 192 0.7× 214 1.2× 288 2.2k
Juan F. López‐Giménez United Kingdom 24 2.0k 1.5× 1.6k 1.5× 116 0.4× 180 0.7× 146 0.8× 39 2.7k
Stephan Urwyler Switzerland 25 2.2k 1.7× 1.7k 1.6× 235 0.8× 142 0.5× 119 0.7× 55 2.8k
Clotilde Mannoury la Cour France 26 1.2k 0.9× 993 0.9× 175 0.6× 211 0.8× 148 0.8× 48 1.9k
Stephen L. Lowe United States 23 1.3k 1.0× 1.2k 1.1× 737 2.4× 437 1.7× 268 1.5× 77 2.8k
Jesse Brodkin United States 18 1.4k 1.1× 1.0k 1.0× 163 0.5× 232 0.9× 82 0.5× 20 1.9k

Countries citing papers authored by Andrew Alt

Since Specialization
Citations

This map shows the geographic impact of Andrew Alt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Alt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Alt more than expected).

Fields of papers citing papers by Andrew Alt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Alt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Alt. The network helps show where Andrew Alt may publish in the future.

Co-authorship network of co-authors of Andrew Alt

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Alt. A scholar is included among the top collaborators of Andrew Alt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Alt. Andrew Alt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Dike, Ke Xu, Namjin Chung, et al.. (2023). Identification and validation of G protein-coupled receptors modulating flow-dependent signaling pathways in vascular endothelial cells. Frontiers in Molecular Biosciences. 10. 1198079–1198079. 2 indexed citations
2.
Gliozzi, M., et al.. (2023). Comparing indirect methods for black hole masses in AGN: the good, the bad, and the ugly. Monthly Notices of the Royal Astronomical Society. 528(2). 3417–3432. 4 indexed citations
3.
Traynor, John R., et al.. (2021). Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators. Frontiers in Chemistry. 9. 671483–671483. 12 indexed citations
4.
Alt, Andrew, et al.. (2019). Identification and biochemical analyses of selective CB2 agonists. European Journal of Pharmacology. 854. 1–8. 8 indexed citations
5.
Burford, Neil T., John B. Watson, & Andrew Alt. (2017). Standard Curves Are Necessary to Determine Pharmacological Properties for Ligands in Functional Assays Using Competition Binding Technologies. Assay and Drug Development Technologies. 15(7). 320–329. 2 indexed citations
6.
Livingston, Kathryn E., et al.. (2017). Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors. Molecular Pharmacology. 93(2). 157–167. 38 indexed citations
7.
Winters, Bryony L., Gabrielle C. Gregoriou, Sam M. Hermes, et al.. (2017). Endogenous opioids regulate moment-to-moment neuronal communication and excitability. Nature Communications. 8(1). 14611–14611. 53 indexed citations
8.
Burford, Neil T., John R. Traynor, & Andrew Alt. (2014). Positive allosteric modulators of the μ‐opioid receptor: a novel approach for future pain medications. British Journal of Pharmacology. 172(2). 277–286. 76 indexed citations
9.
Burford, Neil T., Tom S. Wehrman, Daniel L. Bassoni, et al.. (2014). Identification of Selective Agonists and Positive Allosteric Modulators for µ- and δ-Opioid Receptors from a Single High-Throughput Screen. SLAS DISCOVERY. 19(9). 1255–1265. 28 indexed citations
10.
Zhu, Ying‐Jie, John B. Watson, Mengjie Chen, et al.. (2014). Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists. SLAS DISCOVERY. 19(7). 1079–1089. 10 indexed citations
11.
Noblin, Devin J., Robert L. Bertekap, Neil T. Burford, et al.. (2012). Development of a High-Throughput Calcium Flux Assay for Identification of All Ligand Types Including Positive, Negative, and Silent Allosteric Modulators for G Protein-Coupled Receptors. Assay and Drug Development Technologies. 10(5). 457–467. 11 indexed citations
12.
Burford, Neil T., John B. Watson, Robert L. Bertekap, & Andrew Alt. (2010). Strategies for the identification of allosteric modulators of G-protein-coupled receptors. Biochemical Pharmacology. 81(6). 691–702. 67 indexed citations
13.
Alt, Andrew, Paul L. Ornstein, Scott D. Gleason, et al.. (2007). Anxiolytic-like effects through a GLUK5 kainate receptor mechanism. Neuropharmacology. 52(7). 1482–1487. 19 indexed citations
14.
Bleakman, David, Andrew Alt, & J M Witkin. (2007). AMPA Receptors in the Therapeutic Management of Depression. CNS & Neurological Disorders - Drug Targets. 6(2). 117–126. 99 indexed citations
15.
Alt, Andrew, Ann Marie L. Ogden, Xia Li, et al.. (2006). In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders. Psychopharmacology. 185(2). 240–247. 27 indexed citations
16.
Bleakman, David, Andrew Alt, & Eric S. Nisenbaum. (2006). Glutamate receptors and pain. Seminars in Cell and Developmental Biology. 17(5). 592–604. 218 indexed citations
17.
Dolman, Nigel P., Julia C. A. More, Andrew Alt, et al.. (2006). Structure−Activity Relationship Studies on N3-Substituted Willardiine Derivatives Acting as AMPA or Kainate Receptor Antagonists. Journal of Medicinal Chemistry. 49(8). 2579–2592. 49 indexed citations
18.
Alt, Andrew, Eric S. Nisenbaum, David Bleakman, & Jeffrey M. Witkin. (2006). A role for AMPA receptors in mood disorders. Biochemical Pharmacology. 71(9). 1273–1288. 190 indexed citations
19.
20.
Remmers, Ann E., Mary J. Clark, Andrew Alt, et al.. (2000). Activation of G protein by opioid receptors: role of receptor number and G-protein concentration. European Journal of Pharmacology. 396(2-3). 67–75. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael P. Johnson Breakdown of academic impact, for papers by David O. Calligaro Breakdown of academic impact, for papers by Т. А. Гудашева Breakdown of academic impact, for papers by Theresa Kopajtic Breakdown of academic impact, for papers by С. Б. Середенин Breakdown of academic impact, for papers by Juan F. López‐Giménez Breakdown of academic impact, for papers by Stephan Urwyler Breakdown of academic impact, for papers by Clotilde Mannoury la Cour Breakdown of academic impact, for papers by Stephen L. Lowe Breakdown of academic impact, for papers by Jesse Brodkin
Rankless by CCL
2026